Abstract: Compositions are provided comprising chito-oligomers obtainable from chitin, comprising oligomers of N-acetyl glucosamine (NAG) and glucosamine, wherein at least 50% of the oligomers have a chain length of about 2-50, and the degree of deacetylation of the oligomers is in the range of about 0-70%, preferably about 30-50%. The compositions are highly useful as pharmaceutical compositions for treatment of joint disorders such as rheumatoid arthritis and osteoarthritis. Also provided are methods for treatment of joint disorders and treatment against inflammatory activity.
Type:
Grant
Filed:
June 20, 2011
Date of Patent:
April 9, 2013
Assignee:
Genis Ehf.
Inventors:
Johannes Gislason, Martin Peter, Jon M. Einarsson, Sven Bahrke
Abstract: Compositions are provided comprising chito-oligomers obtainable from chitin, comprising oligomers of N-acetyl glucosamine (NAG) and glucosamine, wherein at least 50% of the oligomers have a chain length of about 2-50, and the degree of deacetylation of the oligomers is in the range of about 0-70%, preferably about 30-50%. The compositions are highly useful as pharmaceutical compositions for treatment of joint disorders such as rheumatoid arthritis and osteoarthritis. Also provided are methods for treatment of joint disorders and treatment against inflammatory activity.
Type:
Grant
Filed:
September 26, 2002
Date of Patent:
July 26, 2011
Assignee:
Genis EHF.
Inventors:
Johannes Gislason, Martin Peter, Jon M. Einarsson, Sven Bahrke